Your browser doesn't support javascript.
loading
Characterization of orofacial features in sclerodermatous chronic graft-versus-host disease.
Bajonaid, Amal; Guntaka, Praveen Kumar; Harper, Matthew; Cutler, Corey; Duncan, Christine; Villa, Alessandro; Sroussi, Hervé Y; Woo, Sook-Bin; Treister, Nathaniel S.
Afiliación
  • Bajonaid A; College of Dentistry, Jazan University, Jazan, Saudi Arabia.
  • Guntaka PK; OMFS Candidate, Mount Sinai Health System, New York, New York, USA.
  • Harper M; Department of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
  • Cutler C; Department of Dentistry, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Duncan C; Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Villa A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Sroussi HY; Department of Orofacial Sciences, University of California San Francisco, San Francisco, California, USA.
  • Woo SB; Herbert Wertheim College of Medicine and Miami Cancer Institute, Miami, Florida, USA.
  • Treister NS; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
Oral Dis ; 2024 Mar 21.
Article en En | MEDLINE | ID: mdl-38514965
ABSTRACT

BACKGROUND:

Chronic graft-versus-host disease (cGVHD) is a leading cause of morbidity and mortality following allogeneic hematopoietic cell transplantation (alloHCT). The sclerodermatous form of cGVHD can be particularly debilitating; however, orofacial sclerodermatous involvement remains poorly described.

OBJECTIVE:

To characterize orofacial features of sclerodermatous cGVHD in a single center cohort of patients who underwent alloHCT. STUDY

DESIGN:

Retrospective data were collected from electronic medical records and analyzed descriptively.

RESULTS:

There were 39 patients who received alloHCT between 1993 and 2017 and developed orofacial sclerodermatous cGVHD. Concomitant cutaneous sclerodermatous cGVHD was common (n = 20, 51%). Orofacial sclerodermatous cGVHD features included fibrous bands of the buccal mucosa (n = 23, 59%), limited mouth opening (n = 19, 54%), perioral fibrosis (n = 8, 21%), and focal gingival recession (n = 4, 10%). Oral mucosal fibrosis was observed at the site of active or resolved chronic lichenoid inflammation in 30 patients, with all but two also presenting with a history of ulcerations. Management included jaw stretching exercises (n = 10; 6 stable/improved), surgery (n = 3; 2 improved), and intralesional corticosteroid injections (n = 2; 2 improved).

CONCLUSIONS:

Orofacial involvement with sclerodermatous cGVHD can present with multiple manifestations including fibrous banding, limited mouth opening, perioral fibrosis, and focal gingival recession. Surgical and non-surgical management strategies may improve clinical function and reduce morbidity.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oral Dis Asunto de la revista: ODONTOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Oral Dis Asunto de la revista: ODONTOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Arabia Saudita